SNAP Biosciences licenses Monarch's cell therapy tech#SNAP #Biosciences #licenses #Monarch039s #cell #therapy #tech
Tag: Therapy
Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency…
Spur Therapeutics reports progress in gene therapy trials
Spur Therapeutics reports progress in gene therapy trials#Spur #Therapeutics #reports #progress #gene #therapy #trials
Plus Therapeutics reports progress in CNS cancer therapy
Plus Therapeutics reports progress in CNS cancer therapy#Therapeutics #reports #progress #CNS #cancer #therapy
Apple Music introduces Sound Therapy, songs for focusing, relaxing and sleep
Apple Music is introducing a new “audio wellness” collection of songs called Sound Therapy. Designed in…
Regenxbio stock rises on FDA's priority review for MPS II therapy
Regenxbio stock rises on FDA's priority review for MPS II therapy#Regenxbio #stock #rises #FDA039s #priority #review…
FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer
FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated…
BioCryst: Strong Opportunity For A Double With A Proven Therapy
BioCryst: Strong Opportunity For A Double With A Proven Therapy #BioCryst #Strong #Opportunity #Double #Proven #Therapy
KEYTRUDA ® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally
KEYTRUDA ® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free…
Neurocrine Biosciences: Valbenazine As Adjunctive Therapy Could Stage Comeback In 2025
Neurocrine Biosciences: Valbenazine As Adjunctive Therapy Could Stage Comeback In 2025 #Neurocrine #Biosciences #Valbenazine #Adjunctive #Therapy…
uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130
uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130 #uniQure #Bullish #NearTerm #Catalysts #Breakthrough…
UniQure N.V. (QURE) Soars on FDA Breakthrough Therapy Designation for Huntington’s Disease Treatment
As of this writing, UniQure N.V.’s stock price has surged 35.89% to $12.79 per share after…
Genflow Biosciences enters AI gene therapy research deal
Genflow Biosciences enters AI gene therapy research deal#Genflow #Biosciences #enters #gene #therapy #research #deal
Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space
Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space #Solid #Biosciences…
Vertex Pharmaceuticals: A Look At Their Pain Therapy Program
Vertex Pharmaceuticals: A Look At Their Pain Therapy Program #Vertex #Pharmaceuticals #Pain #Therapy #Program
New gene therapy and SPAC merger up big today
*Together with TheSteadyTrader & The Opportunistic Trader Happy Tuesday, 360 – Here are some of our…
FDA fast tracks NKGen's Alzheimer's therapy troculeucel
FDA fast tracks NKGen's Alzheimer's therapy troculeucel#FDA #fast #tracks #NKGen039s #Alzheimer039s #therapy #troculeucel
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory…
CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline
CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO…
Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success
Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success #Sana #Biotechnology #Stock #Price #Rise…
Galapagos Stock Struggles To Carve A Path In A Crowded CAR-T Therapy Market (NASDAQ:GLPG)
This article was written by Follow I’m a stock analyst with an MBA and a background…